US equities
|
SPCX
$147.79
▲+0.00%
NVDA
$216.47
▲+0.00%
MU
$896.07
▲+0.00%
TSLA
$373.71
▲+0.00%
SNDK
$1,365.38
▲+0.00%
GOOGL
$340.27
▲+0.00%
NFLX
$68.69
▲+0.00%
AMD
$534.74
▲+0.00%
SPCX
$147.79
▲+0.00%
NVDA
$216.47
▲+0.00%
MU
$896.07
▲+0.00%
TSLA
$373.71
▲+0.00%
SNDK
$1,365.38
▲+0.00%
GOOGL
$340.27
▲+0.00%
NFLX
$68.69
▲+0.00%
AMD
$534.74
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Klinic Ottakring
Recent news which mentions Klinic Ottakring
Austrian skin cancer patients take part in EPIC-Skin clinical study
March 15, 2022
Tags
Rhenium/188
Skin Cancer Therapy
Munich
From
PRLog